European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-24

Molecular mechanisms of disease progression and renoprotective pharmacotherapy in children with chronic renal failure

Objectif

ACE inhibitors are renoprotective in adults with chronic renal failure (CRF), but of unproven usefulness in children. In a randomised trial in 350 CRF children we will address if ACE inhibition is efficacious in slowing CRF progression in acquired and congenital nephropathies, if progression can be additionally influenced by intensified antihypertensive treatment achieving low-normal blood pressure, and which factors determine CRF progression and/or its susceptibility to ACE inhibition. Potential effects of renin-angiotensin system and PAI-l gene polymorphisms, mutations in genes defining glomerular structure or causing renal hypo/dysplasia, renal endothelnr-l turnover, plasma homocysteine and apolipoprotein phenotypes will be assessed. The cardiovascular consequences of childhood-onset CRF and renoprotective pharmacotherapy will be addressed by carotid ultrasound, echocardiography and 24-hour blood pressure monitoring.

Champ scientifique

Programme(s)

Thème(s)

Appel à propositions

Data not available

Régime de financement

CSC - Cost-sharing contracts

Coordinateur

UNIVERSITAETSKLINIKUM HEIDELBERG
Contribution de l’UE
Aucune donnée
Adresse
Im Neuenheimer Feld 150
69115 HEIDELBERG
Allemagne

Voir sur la carte
Coût total
Aucune donnée

Participants (27)

Partager cette page

Télécharger

Dernière mise à jour: 9 Decembre 2005

Mon livret

Permalink: https://cordis.europa.eu/project/id/QLG1-CT-2002-00908/fr

European Union, 2024